MHRA-101618-PIP01-24-M02 (update)

Key Facts

Active Substance
Active Substance:
  • ADRENALINE
Invented Name
  • EURneffy 2 mg nasal spray, solution in single-dose container
  • EURneffy 2 mg nasal spray, solution in single-dose container
  • EURneffy 2 mg nasal spray, solution in single-dose container
  • NEFFY
PIP Number MHRA-101618-PIP01-24-M02 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Nasal spray, solution
Therapeutic area
Therapeutic area:
  • Pneumology - Allergology
Conditions / Indications
Conditions / Indications:
  • Treatment of allergic reactions
Route(s) of administration
Route(s) of administration:
  • NASAL USE
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
Yes
Compliance Check Decision Date
Compliance opinion date
24/02/2026
Compliance Check Procedure Number
Compliance procedure number
MHRA-101618-PIP01-24-M02-C1

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):ADRENALINE.pdf
Published Date 16/07/2026